TipRanks
Immuno-Biological Laboratories Co., Ltd. (JP:4570)
:4570
Japanese Market
4570
Immuno-Biological Laboratories Co., Ltd.
RESEARCH TOOLSreports
Want to see JP:4570 full AI Analyst Report?

Immuno-Biological Laboratories Co., Ltd. (4570) Ratios

0 Followers

Immuno-Biological Laboratories Co., Ltd. Ratios

JP:4570's free cash flow for Q1 2026 was ¥0.78. For the 2026 fiscal year, JP:4570's free cash flow was decreased by ¥ and operating cash flow was ¥0.41. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
 5.18 5.68 4.94 4.90 4.62
Quick Ratio
 3.80 4.31 3.81 3.65 3.36
Cash Ratio
 3.01 3.58 2.94 2.85 2.44
Solvency Ratio
 1.14 1.11 0.80 0.54 -0.96
Operating Cash Flow Ratio
 0.00 1.09 0.65 0.52 0.10
Short-Term Operating Cash Flow Coverage
 0.00 1.90 1.08 0.88 0.19
Net Current Asset Value
¥ 1.22B¥ 1.26B¥ 1.06B¥ 908.85M¥ 809.57M
Leverage Ratios
Debt-to-Assets Ratio
 0.08 0.08 0.11 0.15 0.16
Debt-to-Equity Ratio
 0.09 0.10 0.13 0.19 0.22
Debt-to-Capital Ratio
 0.08 0.09 0.12 0.16 0.18
Long-Term Debt-to-Capital Ratio
 <0.01 0.01 0.02 0.06 0.08
Financial Leverage Ratio
 1.18 1.17 1.22 1.28 1.33
Debt Service Coverage Ratio
 2.48 2.05 1.56 1.25 -2.49
Interest Coverage Ratio
 267.58 211.01 166.15 92.30 54.40
Debt to Market Cap
 0.02 0.01 0.05 0.05 0.06
Interest Debt Per Share
 18.59 19.16 22.06 25.46 25.35
Net Debt to EBITDA
 -2.00 -2.71 -2.74 -3.89 1.14
Profitability Margins
Gross Profit Margin
72.02%69.68%64.81%63.34%66.28%
EBIT Margin
32.38%27.99%21.78%15.40%-35.18%
EBITDA Margin
34.12%29.83%23.37%15.69%-41.78%
Operating Profit Margin
31.93%27.99%21.59%12.77%7.35%
Pretax Profit Margin
32.54%29.91%21.65%15.26%-35.31%
Net Profit Margin
34.12%32.74%25.69%22.86%-36.46%
Continuous Operations Profit Margin
34.12%32.74%25.69%22.86%-36.46%
Net Income Per EBT
104.84%109.47%118.67%149.78%103.25%
EBT Per EBIT
101.93%106.86%100.25%119.51%-480.72%
Return on Assets (ROA)
16.55%15.27%13.49%11.53%-20.20%
Return on Equity (ROE)
20.61%17.85%16.45%14.75%-26.86%
Return on Capital Employed (ROCE)
17.91%14.97%13.38%7.66%4.94%
Return on Invested Capital (ROIC)
16.58%13.81%12.07%6.90%4.43%
Return on Tangible Assets
16.55%15.28%13.50%11.55%-20.20%
Earnings Yield
3.33%2.63%5.57%3.89%-7.64%
Efficiency Ratios
Receivables Turnover
 4.93 5.62 4.19 4.29 3.67
Payables Turnover
 49.75 101.84 91.72 68.91 47.03
Inventory Turnover
 0.73 0.80 1.07 0.93 0.84
Fixed Asset Turnover
 5.14 4.71 5.07 6.01 6.66
Asset Turnover
 0.48 0.47 0.53 0.50 0.55
Working Capital Turnover Ratio
 0.85 0.84 0.92 0.85 0.88
Cash Conversion Cycle
 568.82 516.17 423.11 472.19 524.86
Days of Sales Outstanding
 74.02 64.89 87.17 85.05 99.36
Days of Inventory Outstanding
 502.14 454.86 339.93 392.44 433.26
Days of Payables Outstanding
 7.34 3.58 3.98 5.30 7.76
Operating Cycle
 576.16 519.75 427.09 477.49 532.63
Cash Flow Ratios
Operating Cash Flow Per Share
 0.00 32.33 19.70 14.36 2.84
Free Cash Flow Per Share
 0.00 28.74 13.30 12.36 2.84
CapEx Per Share
 0.00 3.59 6.41 2.00 0.00
Free Cash Flow to Operating Cash Flow
 0.00 0.89 0.67 0.86 1.00
Dividend Paid and CapEx Coverage Ratio
 0.00 3.37 3.08 7.17 0.00
Capital Expenditure Coverage Ratio
 0.00 9.01 3.08 7.17 0.00
Operating Cash Flow Coverage Ratio
 0.00 1.70 0.90 0.57 0.11
Operating Cash Flow to Sales Ratio
 0.00 0.30 0.19 0.16 0.03
Free Cash Flow Yield
0.00%2.14%2.77%2.40%0.70%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 29.99 37.98 17.95 25.69 -13.08
Price-to-Sales (P/S) Ratio
 10.23 12.44 4.61 5.87 4.77
Price-to-Book (P/B) Ratio
 5.85 6.78 2.95 3.79 3.51
Price-to-Free Cash Flow (P/FCF) Ratio
 0.00 46.69 36.10 41.67 143.27
Price-to-Operating Cash Flow Ratio
 0.00 41.51 24.36 35.85 143.27
Price-to-Earnings Growth (PEG) Ratio
 0.71 1.18 0.54 -0.16 -1.09
Price-to-Fair Value
 5.85 6.78 2.95 3.79 3.51
Enterprise Value Multiple
 27.99 38.98 16.99 33.55 -10.28
Enterprise Value
 10.31B 11.69B 3.85B 4.30B 3.41B
EV to EBITDA
 27.99 38.98 16.99 33.55 -10.28
EV to Sales
 9.55 11.63 3.97 5.26 4.29
EV to Free Cash Flow
 0.00 43.66 31.08 37.34 128.94
EV to Operating Cash Flow
 0.00 38.81 20.98 32.13 128.94
Tangible Book Value Per Share
 202.57 197.79 162.41 135.61 115.81
Shareholders’ Equity Per Share
 202.69 197.93 162.60 135.86 115.81
Tax and Other Ratios
Effective Tax Rate
 -0.05 -0.09 -0.19 -0.50 -0.03
Revenue Per Share
 115.91 107.91 104.10 87.69 85.32
Net Income Per Share
 39.55 35.33 26.74 20.05 -31.11
Tax Burden
 1.05 1.09 1.19 1.50 1.03
Interest Burden
 1.01 1.07 0.99 0.99 1.00
Research & Development to Revenue
 0.00 0.12 0.12 0.16 0.23
SG&A to Revenue
 0.40 0.30 0.31 <0.01 0.06
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.00 0.92 0.74 0.72 -0.12
Currency in JPY